Mission Statement

The Swiss Rockets’ mission is to deliver outstanding results for patients, investors, and inventors.

Swiss Rockets brings entrepreneurs together with breakthrough technologies and therapies and the best development experts in the field.

Dr. Vladimir Cmiljanovic
Dr. Vladimir CmiljanovicChief Executive Officer & Founder
Dr. Natasa Cmiljanovic
Dr. Natasa CmiljanovicChief Scientific Officer & Founder
Dr. Thomas Sander
Dr. Thomas SanderScientific Advisor & Co-Founder
Manuel Ebner
Manuel EbnerMember of Business Advisory Committee & Co-Founder

Swiss Rockets Entrepreneurship

Swiss Rockets brings entrepreneurs together with breakthrough technologies and the best development experts in the field.

We are looking forward to hearing from you!

We invite you to contact us with new product ideas, cooperation opportunities, information for patients, or general comments.

Contact US now!

Our Values and Uniqueness

Patients First

We value all stakeholders but give priority to patients.

We conduct our business with the patients’ well-being in mind. Integrity, honesty, loyalty, and trust form the foundation on which we build our company and future success. All our investments, entrepreneurs, partners, and therapies always put the patients first.

Self-Sufficient Model

Swiss Rockets is designed to be self-sufficient, just like large pharmaceutical groups. Still, with one crucial difference:

We empower people to be entrepreneurs and enable them to benefit long term from their inventions. We are proud to be part of each project in our innovation hub. We want our entrepreneurs to feel motivated to invent the best possible cures for patients around the world.

Self-Sufficient Model

Swiss Rockets is designed to be self-sufficient, just like large pharmaceutical groups. Still, with one crucial difference: 

We empower people to be entrepreneurs and enable them to benefit long term from their inventions. We are proud to be part of each project in our innovation hub. We want our entrepreneurs to feel motivated to invent the best possible cures for patients around the world.

Active Involvement

We have a rigorous selection process when choosing new technologies because we invest money, time, and infrastructure into each project.

Companies that decide to work with us are getting more than just an investor; we actively participate in the drug development process and share our entrepreneurial experience, expertise, and infrastructure to ensure that the process from idea to commercialization is as efficient as possible.

Board of Directors

Dr. Vladimir Cmiljanovic
Dr. Vladimir CmiljanovicChairman
André Debrunner
André DebrunnerVice-Chairman
Dr. Natasa Cmiljanovic
Dr. Natasa CmiljanovicMember
Dr. Thomas Ladner
Dr. Thomas LadnerMember & Secretary
Prof. Dr. Michael N. Hall
Prof. Dr. Michael N. HallMember

Startup Services

Swiss Rockets provides integrated services through active involvement in the management, drug development, and business development activities of startups. Our experts are ready to help startups achieve their goals.

  • Preclinical and Clinical drug development
  • API manufacturing
  • Drug formulation / packaging / labelling
  • Quality assurance
  • Quality management

  • General business support
  • Legal
  • Human resources
  • Intellectual property
  • Management
  • Investments
  • Sales & Marketing
  • IPO and M&A

  • Shared office space in Basel
  • Shared lab space
  • Secretarial services
  • IT infrastructure and services
  • Presence in media

  • Business coaching
  • Collaboration initiatives
  • Region-specific business etiquette
  • Entrepreneurial training sessions and workshops
  • Networking events
  • Partnership programmes with universities

Our Most Important Stakeholders Are the Patients

All of our projects, investments, and partnerships focus on serving cancer patients and providing for their long-term well-being.

Portfolio

Our portfolio of businesses includes internal projects, spin-off companies, joint ventures with startup companies, and distribution partnerships. A well-diversified portfolio is essential for us to mitigate the risks of individual investments. We focus our efforts on the following industry sectors:

Generic Cancer
Drugs

Most cancer patients rely on the availability of generic oncology medication. We want to make products with exceptional Swiss quality available to patients in countries that currently suffer from supply shortages or high prices.

Targeted Cancer
Therapies

Targeted cancer therapies are drugs that are designed to block the growth and spread of cancer by interfering with specific molecular targets that are involved in the growth, metabolism, progression, and metastasis of cancer cells. Unlike conventional cancer therapies such as chemotherapy, which targets healthy and cancer cells at the same time, targeted therapies are designed to address specific molecular mutations within cancer cells.

Cancer Immuno
Therapies

Cancer immunotherapy stimulates the immune system to fight cancer. We are pursuing new approaches that are designed to cure more patients with fewer side effects.

Personalized
Cancer Therapies

Personalized cancer therapy is a treatment strategy that predicts which patients are more likely to respond to specific cancer therapies. This approach uses specific tumor biomarkers that predict therapy response. We use the sequencing of tumor DNA to reveal genomic alterations and develop perzonalized therapies for treatment-resistant cancers.

Cancer
Prevention

We could prevent a significant number of cancer deaths by avoiding risk factors such as tobacco, overweight, an insufficient diet, physical inactivity, alcohol, sexually transmitted infections, and air pollution. We are developing gene-editing techniques and drugs that may serve as preventative measures.

Innovative MedTech
Devices & Distribution

Drug development is a lengthy and costly process. We have identified several fully approved products that are in the market and can immediately generate returns for our investors while providing us with additional funding to continue our breakthrough drug development efforts.

What Makes Us Different

Creating breakthrough drugs and technologies to fight cancer is a very time-consuming business. We seek investors who, like us, are in it for the long haul.

Executive Management

Dr. Vladimir Cmiljanovic
Dr. Vladimir CmiljanovicChief Executive Officer
Dr. Natasa Cmiljanovic
Dr. Natasa CmiljanovicChief Scientific Officer
Dr. Mohammad Johri
Dr. Mohammad JohriDeputy CEO
Dr. Andreas Voss
Dr. Andreas VossChief Operating Officer
Dr. Josef Künzle
Dr. Josef KünzleChief Quality Officer

Extended Executive Management

Maciej Talarek
Maciej TalarekHead of Finance
Michel Petignat
Michel PetignatHead of Human Resources
Emir Iljazovic
Emir IljazovicHead of Business Operations
Saif Al-Rubai
Saif Al-RubaiHead of Legal and Corporate Development

Business Advisory Committee

Dr. Sabina R. Korfmann-Bodenmann
Dr. Sabina R. Korfmann-BodenmannChairman
Christoph Rentsch
Christoph RentschVice-Chairman
Manuel Ebner
Manuel EbnerMember & Co-Founder
Sergey Shneyerson
Sergey ShneyersonMember

Scientific and Drug Discovery Advisory Committee

Dr. Jeanette Wood
Dr. Jeanette WoodChairman
Prof. Dr. Stephane Depil
Prof. Dr. Stephane DepilMember
Dr. Marc Lang
Dr. Marc LangMember
Dr. Donald Ogilvie
Dr. Donald OgilvieMember
Dr. Thomas Sander
Dr. Thomas SanderMember
Dr. Paul Hebeisen
Dr. Paul HebeisenMember
Dr. Doriano Fabbro
Dr. Doriano FabbroMember

Oncology Advisory Committee

Prof. Dr. med. Alex A. Adjei
Prof. Dr. med. Alex A. AdjeiChairman
Prof. Dr. med. Solange Peters
Prof. Dr. med. Solange PetersVice-Chairman
Prof. Dr. med. Richard Herrmann
Prof. Dr. med. Richard HerrmannMember
Prof. Dr. med. Jean-Yves Blay
Prof. Dr. med. Jean-Yves BlayMember
Prof. Dr. med. Filip Janku
Prof. Dr. med. Filip JankuMember
Prof. Dr. med. Semir Beslija
Prof. Dr. med. Semir BeslijaMember

Contact Us

We are looking forward to hearing from you

HEADQUARTERS

How can we help you?